• About
  • Offices
  • Careers
  • News
  • Students
  • Alumni
  • Payments
  • EN | FR
Background Image
Bennett Jones Logo
  • People
  • Expertise
  • Knowledge
  • Search
  • FR Menu
  • Search Mobile
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
View all
Practices
Corporate Litigation Regulatory Tax View all
Industries
Energy Infrastructure Mining Private Equity & Investment Funds View all
Advisory
Crisis & Risk Management Public Policy
View Client Work
International Experience
Insights News Events Subscribe
Arbitration Angle Artificial Intelligence Insights Business Law Talks Podcast Class Actions: Looking Forward Class Action Quick Takes
Economic Outlook New Energy Economy Series Private Equity Briefings Quarterly Fintech Insights Quarterly M&A Insights
Sustainability & the CIO
People
Offices
About
Practices
Industries
Advisory Services
Client Work
Insights
News
Events
Careers
Law Students
Alumni
Payments
Search
Subscribe

Stay informed on the latest business and legal insights and events.

LinkedIn LinkedIn Twitter Twitter Vimeo Vimeo
 

MS Progression Cohort Moves Forward, Helped by Bennett Jones $1 Million Multi-Year Donation

December 06, 2018

The Multiple Sclerosis Society of Canada and Brain Canada Foundation announced today the selected team to lead the Canadian cohort to study the progression of multiple sclerosis (MS). Dr. Jiwon Oh, based at St. Michael’s Hospital, and her team of nearly 50 leading MS researchers in multiple disciplines from across the country, have been chosen to lead the $7+ million Canadian Proactive Cohort Study for People Living with MS (CanProCo).


In December 2016, Bennett Jones announced its $1 million multi-year donation to the Cohort Study. Canada has the highest rate of multiple sclerosis in the world, with an estimated 100,000 Canadians living with the disease.


The CanProCo is the first project of its kind in Canada aiming to gain a better understanding of the unpredictable nature of disease progression. In addition to understanding why some people progress in their disease and some people do not, researchers will also try to pinpoint triggers leading to progression and establish methods of managing those triggers while also measuring the impact of MS on individuals as well as the Canadian healthcare system.

Click here for more information about the Canadian MS Progression Cohort.

Related Links

  • Insights
  • Media
  • Subscribe

Recent Posts

Articles

Tariff Tensions: Managing Risk Through Carefully Drafted Construction Contracts

July 21, 2025
       

Speaking Engagements

Sabrina Bandali spoke at the 71 Annual Natural Resources

July 17, 2025
       

Client Work

Canada Infrastructure Bank Closes C$1 Billion Financing to Support Montréal-Trudeau Transformation

July 16, 2025
       

In The News

John Manley on the CBC News Network

July 11, 2025
       

Speaking Engagements

Rethinking Cyber Risk in the Age of AI: What Boards Need to Know

July 08, 2025
       

Announcements

Eighteen Bennett Jones Lawyers Ranked in Lexpert's Special Edition on Health Sciences

July 02, 2025
       

Client Work

Bennett Jones Acts for Canadian Pacific Kansas City Limited in Overturning C$228 Million Judgment

July 02, 2025
       

Announcements

Harinder Basra Appointed Calgary Managing Partner at Bennett Jones

July 01, 2025
       

Announcements

John Manley Appointed Companion of the Order of Canada

June 30, 2025
       
Bennett Jones Centennial Footer
Bennett Jones Centennial Footer
About
  • Leadership
  • Diversity
  • Community
  • Innovation
  • Security
Offices
  • Calgary
  • Edmonton
  • Montréal
  • Ottawa
  • Toronto
  • Vancouver
  • New York
Connect
  • Insights
  • News
  • Events
  • Careers
  • Students
  • Alumni
Subscribe

Stay informed on the latest business and legal insights and events.

LinkedIn LinkedIn Twitter Twitter Vimeo Vimeo
© Bennett Jones LLP 2025. All rights reserved.
  • Privacy Policy
  • Disclaimer
  • Terms of Use
Logo Bennett Jones